Definitive Analysis

Financial Statements

Fundamentals

Valuations

Miscellaneous

Analysis Mode

Full Access

See Pricing Start Trial
Multiples Valuation: HCA Healthcare, Inc.

HCA Healthcare, Inc. (0J1R.L)

Industry: Medical - Equipment & Services Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $417.46 — $632.62
Selected (Average) $527.86
Upside to Live 11.60%
Full Range Fair Value
Range (Low - High) $550.08 — $657.40
Selected (Average) $601.13
Upside to Live 27.09%
Live Price $472.99

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
0HTG.L 1 Cardinal Health, I 234,310 23.42 21.22 12.81 11.63 15.64 13.10
0HVB.L 2 Centene Corporatio 179,953 - - - - - -
0J1R.L 3 HCA Healthcare, In 74,372 16.21 14.29 9.91 9.02 12.54 11.49
0PMJ.L 4 Siemens Healthinee 27,447 23.97 22.05 14.03 12.75 17.13 16.80
0R2S.L 5 Stryker Corporatio 24,381 48.03 43.32 33.18 30.39 34.08 25.61
LH 6 Labcorp Holdings I 13,765 27.89 27.83 14.81 14.86 18.78 22.83
0L3C.L 7 Henry Schein, Inc. 12,938 22.85 23.00 12.39 11.74 14.74 14.78
0ROG.L 8 Galenica AG 9,829 11.72 9.68 8.11 6.88 12.11 10.70
CBHD.DE 9 Coloplast A/S 4,381 33.04 32.83 18.05 16.83 21.58 19.65
0MT8.L 10 Drägerwerk AG & C 4,015 9.76 10.56 3.66 3.84 5.53 8.31
NVST 11 Envista Holdings C 2,622 225.05 225.05 11.44 10.05 17.01 17.63
0QB4.L 12 Medios AG 2,363 14.52 11.22 5.23 3.44 9.21 6.84
HIMS 13 Hims & Hers Health 2,211 95.96 95.96 86.19 86.19 288.19 118.33
CON 14 Concentra Group Ho 2,089 17.30 17.30 7.97 7.97 8.31 9.70
0NES.L 15 Oriola Oyj 2,057 - - 5.66 6.71 - 24.23
0ELV.L 16 Guerbet S.A. 1,946 6.89 7.38 3.08 2.80 10.57 6.98

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple22.8521.229.779.0114.7413.94
Full Range Median Multiple23.4222.0511.9210.8415.6415.79
Industry Multiple43.1142.1116.9016.1536.3722.54
Market Implied Multiple17.9915.8610.679.7113.4912.37
Company (0J1R.L) Multiple16.2114.299.919.0212.5411.49
(*) Net Income / EBITDA / Revenue6,3757,22914,99716,48511,86012,938
Winsorized Enterprise ValueN/AN/A146,569148,570174,829180,301
Full Range Median Enterprise ValueN/AN/A178,725178,724185,514204,238
(-) Net Debt45,35245,35245,35245,35245,35245,352
Winsorized Equity Value145,658153,385101,217103,218129,477134,949
Full Range Median Equity Value149,309159,392133,373133,372140,162158,886
(/) Shares Outstanding242242242242242242
Winsorized Fair Value$600.75$632.62$417.46$425.71$534.02$556.58
Full Range Median Fair Value$615.81$657.40$550.09$550.08$578.09$655.31
Current Price$472.99$472.99$472.99$472.99$472.99$472.99
Upside / Downside27.01%33.75%-11.74%-10.00%12.90%17.67%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$420.53$442.83$292.22$298.00$373.81$389.61
Buy / Don't BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t Buy